The investment from longevity business builder Maximon will enable Frieda to scale and implement its digital platform and expand its user base.
Frieda Health, a growing Femtech startup based in Berlin, announced a pre-seed
financing of 2.5 million euros from the Maximon Longevity Co-Investment Fund. This financial support is expected to enable Frieda Health to offer revolutionary digital solutions aimed at supporting women during menopause.
Longevity.Technology: Frieda Health is dedicated to creating a holistic digital health platform tailored specifically to the needs of women aged 45 and older. The platform combines medical expertise, psychological support and digital innovation, aiming to support menopause not only as a biological phase, but also as an emotional and psychological life stage, meaning it will holistically help women throughout the menopausal transition and beyond.
Frieda Health plans to use the new funding to scale up its research and development efforts, evolve the digital platform and expand its user base. Frieda has assembled a team with expertise in health data, software development, gynecology and psychology to advance the evolution and implementation of its digital platform.
The team, made up of experts in health data, software development, gynecology and psychology, is tirelessly engaged in the evolution and implementation of this platform.
“After seeing a long-awaited focus on the female menstrual cycle in recent years, it is now time to consider the end of the cycle,” said Valentina Ullrich, CEO and founder of Frieda Health. “The fact that Frieda has secured a significant investment and a strong partner on board is crucial and makes us extremely proud. We look forward to filling the gaps in menopause treatment and thinking beyond.
“‘Positive or healthy aging’ is still perceived negatively or neglected in the broader context of preventive health. And yet, this is precisely where Frieda intends to make a change.”
Longevity.Technology reached out to Ullrich to learn more about the changes in the space that Frieda will help catalyze.
“Recent research highlights the critical role menopause plays in women’s healthy lifespan. “That’s why Frieda starts with holistic menopause support, treatment and research to open the door,” she told us. “In the next steps, we want to take a closer look at the complex interplay between hormonal changes and age-related diseases. Of course, menopause itself, with all its symptoms – mental and physical – is a huge burden on its own, but its impact on the female aging process is largely underestimated. Osteoporosis is only a minor topic here. But we need to focus more on the subject to understand it better. That’s what Frieda is here for.
Ullrich also noted that while it is true that women generally outlive men, the quality of these extra years is often compromised due to poorly managed menopause symptoms and associated health problems.
“At Frieda Health, we are committed to changing this narrative by providing innovative solutions that address the unique health challenges women face during menopause, improving their overall well-being and quality of life during these crucial years and beyond,” she explained. . “The terms ‘positive or healthy aging’ should not be uncomfortable.”
Caroline Wagner, founding partner of Maximon and newly named member of the Frieda Health board of directors, said the longevity business builder is excited to partner with Frieda Health.
“Maximon is committed to supporting businesses that extend people’s lives – maximizing time spent in good health. Recognizing that for half the population, menopause is often the starting point for age-related health problems, we are excited to support Frieda’s mission in tackling this largely neglected issue and underserved market. served.
